Biomarkers of Major Depressive Disorder: Knowing is Half the Battle

Major depressive disorder (MDD) is a heterogeneous disease which is why there are currently no specific methods to accurately test the severity, endophenotype or therapy response. This lack of progress is partly attributed to the complexity and variability of depression, in association with analytic...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Sahil, Singh, Ravinder, Arora, Govind, Dangol, Akriti, Goyal, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851463/
https://www.ncbi.nlm.nih.gov/pubmed/33508785
http://dx.doi.org/10.9758/cpn.2021.19.1.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851463/
https://www.ncbi.nlm.nih.gov/pubmed/33508785
http://dx.doi.org/10.9758/cpn.2021.19.1.12

Ejemplares similares